A large meta-analysis by the University of Birmingham shows that clinically administered nitrous oxide can rapidly reduce symptoms of major and treatment-resistant depression. A single dose acts briefly, while repeated sessions prolong the benefit. The safety profile is favorable with caution regarding possible functional vitamin B12 deficiency; preparations for the first NHS trial are underway.
New systematic research by psychologists from the University of Vienna, Trinity, and Humboldt shows that even a few minutes of dedicated art viewing measurably raises eudaimonic well-being. Effects are recorded in museums, hospitals, and VR. The authors propose incorporating art into health strategies and introduce RAARR guidelines for consistent reporting.
The ultra-thin BISC interface brings a subdural, single-component CMOS chip with a µECoG array of 65,536 contacts and wireless UWB transmission up to 100 Mb/s. Paired with a wearable relay unit and machine learning tools, the system decodes movement, speech, and perception and targets stimulation; short clinical studies began on December 10, 2025.
In the heart of the spiral galaxy NGC 3783, a short-lived, extremely powerful X-ray flash was recorded, after which ultra-fast winds of about 0.2c were formed. Synchronous observations by XRISM and XMM-Newton clearly linked the flash to the formation of the gust for the first time and pointed to magnetic reconnection as the key trigger and mechanism changing the galaxy's environment
Researchers found a “frozen” construction site from 79 AD in the house Domus IX 10, 1 in Pompeii, with piles of dry mixtures, tools, and walls in various phases. Analyses confirm hot mixing with quicklime, lime clasts, and reaction rims that explain the self-healing of Roman mortars.
New analysis by MIT and the PETAL consortium shows that relapse within 12 months (TTR12) in nodal mature T-cell lymphomas strongly predicts poorer five-year outcomes. The signal guides early selection of targeted therapy and enrollment in clinical trials, instead of classic second-line chemotherapy.